Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer

被引:0
作者
Kousuke Hashimoto
Keishiro Aoyagi
Taro Isobe
Kikuo Kouhuji
Kazuo Shirouzu
机构
[1] Kurume University School of Medicine,Department of Surgery
来源
Gastric Cancer | 2014年 / 17卷
关键词
Gastric cancer; CD133; Prognosis; HIF-1α;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:97 / 106
页数:9
相关论文
共 147 条
[21]  
O’Brien CA(1985)Amphicrine cells, dysplasias, and neoplasias Cancer (Phila) 56 2683-2457
[22]  
Pollett A(2010)Prognostic impact of CD133 expression in gastric carcinoma Anticancer Res 30 2453-546
[23]  
Gallinger S(2010)Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma BMC Cancer 10 218-1212
[24]  
Dick JE(2010)Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma Oncol Rep 24 537-3440
[25]  
Ricci-Vitiani L(2010)Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients Oncol Rep 24 1201-1321
[26]  
Lombardi DG(2012)Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer Ann Surg Oncol 19 3432-450
[27]  
Pilozzi E(2011)CD133 is a marker of gland-forming cells in gastric tumors and ox17 is involved in its regulation Cancer Sci 102 1313-undefined
[28]  
Biffoni M(2012)Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer Gastric Cancer 15 440-undefined
[29]  
Todaro M(undefined)undefined undefined undefined undefined-undefined
[30]  
Peschle C(undefined)undefined undefined undefined undefined-undefined